September 12, 2023 — The Radiological Society of North America (RSNA) launched “RSNA Market Insights,” a series of reliable and affordable radiology-centric business reports. An RSNA first, the reports offer key insights from radiologists, including their perspective on important topics, with useful data analytics in a consumable format appropriate for industry business managers. 

September 12, 2023 — Medical imaging Artificial Intelligence (AI) company Qure.ai has announced a pivotal 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AI-enabled chest X-ray solution — qXR, under two critical findings.

September 11, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a transformative change in 

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that the Company will begin its clinical study of its Affinity PET-CT imaging device with Ochsner Clinic Foundation in New Orleans, LA.

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected lesion can provide clinicians with valuable diagnostic information. For example, blood flow through a liver tumor can offer insights into how likely it is that the cancer could spread. The current standard of care for assessing lesion blood flow requires the intravenous injection of an iodinated contrast media that is not well tolerated by some patients.